Abstract
There has been considerable development and implementation of new contraceptive methods over the last 15 years. However, sterilization has remained the most widely used method around the world. Ideally, the procedure should be safe, have a high efficacy, be readily accessible, and be personally and culturally acceptable. The cost for each procedure would be low and the method would be simple, quick, easily learned and be able to be performed in an outpatient setting without general anesthesia. A transuterine method of female sterilization has long been the ideal for the gynecologist. The Essure™ system fulfils many of the criteria, and is the first one to be approved by the US FDA. However, there is still a need for further research to find a device with the success rate of the Essure but without its irreversibility.
Financial & competing interests disclosure
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.